Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate enrollment is closed. New help pages and navigation tools were added to guide users on reading the study record and joining, with a formatting update to the Intervention/Treatment label.
    Difference
    0.4%
    Check dated 2026-06-12T16:09:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.5, replacing the previous v3.5.4 in the page history. This indicates a new page revision was published, likely for minor editorial updates.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:08.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page, indicating a small metadata update. This change does not alter the substantive content or data displayed.
    Difference
    0.1%
    Check dated 2026-05-14T22:29:11.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.2 to v3.5.3, indicating a new build of the page. The listed change does not alter study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-04-30T17:07:27.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:13:27.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to study details or page behavior.
    Difference
    0.1%
    Check dated 2026-03-18T19:18:10.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.